RASSF1A Suppression as a Potential Regulator of Mechano-Pathobiology Associated with Mammographic Density in BRCA Mutation Carriers
Authors:
- Gina ReyeGRGina Reye
- Xuan HuangXHXuan Huang
- Kara L. BrittKBKara L. Britt
- Christoph MeinertChristoph Meinert
- Tony BlickTBTony Blick
- Yannan XuYXYannan Xu
- Konstantin I. MomotKMKonstantin I. Momot
- Thomas LloydTLThomas Lloyd
- Jason J. NortheyJNJason J. Northey
- Erik W. ThompsonETErik W. Thompson
- Honor J. HugoHHHonor J. Hugo
Open Access
Abstract
High mammographic density (MD) increases breast cancer (BC) risk and creates a stiff tissue environment. BC risk is also increased in BRCA1/2 gene mutation carriers, which may be in part due to genetic disruption of the tumour suppressor gene Ras association domain family member 1 (RASSF1A), a gene that is also directly regulated by tissue stiffness. High MD combined with BRCA1/2 mutations further increase breast cancer risk, yet BRCA1/2 mutations alone or in combination do not increase MD. The molecular basis for this additive effect therefore remains unclear. We studied the interplay between MD, stiffness, and BRCA1/2 mutation status in human mammary tissue obtained after prophylactic mastectomy from women at risk of developing BC. Our results demonstrate that RASSF1A expression increased in MCF10DCIS.com cell cultures with matrix stiffness up until ranges corresponding with BiRADs 4 stiffnesses (~16 kPa), but decreased in higher stiffnesses approaching malignancy levels (>50 kPa). Similarly, higher RASSF1A protein was seen in these cells when co-cultivated with high MD tissue in murine biochambers. Conversely, local stiffness, as measured by collagen I versus III abundance, repressed RASSF1A protein expression in BRCA1, but not BRCA2 gene mutated tissues; regional density as measured radiographically repressed RASSF1A in both BRCA1/2 mutated tissues. The combinatory effect of high MD and BRCA mutations on breast cancer risk may be due to RASSF1A gene repression in regions of increased tissue stiffness.Keywords
Funding Information
- PA Research Foundation (Research Innovation Award)
This publication has 37 references indexed in Scilit:
- Aligned Collagen Is a Prognostic Signature for Survival in Human Breast CarcinomaThe American Journal of Pathology, 2011
- Is Mammographic Breast Density a Breast Cancer Risk Factor in Women With BRCA Mutations?Journal of Clinical Oncology, 2010
- Epithelial Mesenchymal Transition Traits in Human Breast Cancer Cell Lines Parallel the CD44hi/CD24lo/- Stem Cell Phenotype in Human Breast CancerJournal of Mammary Gland Biology and Neoplasia, 2010
- Mammographic density does not differ between unaffected BRCA1/2 mutation carriers and women at low-to-average risk of breast cancerBreast Cancer Research and Treatment, 2010
- Collagen density promotes mammary tumor initiation and progressionBMC Medicine, 2008
- RASSF1APolymorphism A133S Is Associated with Early Onset Breast Cancer inBRCA1/2Mutation CarriersCancer Research, 2008
- Mammographic Density and Breast Cancer Risk in BRCA1 and BRCA2 Mutation CarriersCancer Research, 2006
- Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 StudiesThe American Journal of Human Genetics, 2003
- The RASSF1A Tumor Suppressor Blocks Cell Cycle Progression and Inhibits Cyclin D1 AccumulationMolecular and Cellular Biology, 2002
- Methylation associated inactivation of RASSF1A from region 3p21.3 in lung, breast and ovarian tumoursOncogene, 2001